Archive - November 2020
The Metformin ER Recalls Do Not Stop
Gilead’s remdesivir not included in WHO’s COVID-19 drug scheme
Novartis’ canakinumab failed to improve survival in COVID-19 study
Merck strengthens oncology pipeline with $2.75bn VelosBio deal
Open Orphan announces £2.5m influenza challenge study contract
Vertex’s Kalydeco scores another label extension in EU
NICE backs AbbVie’s Rinvoq for severe active rheumatoid arthritis
Lynparza scores two new EU approvals